|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02162 KEYMED BIO-B
Nominal 
38.200 -1.300 (-3.291%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -9.196% | -7.833% | -174.147% | -137.748% | -25.435% |
| ROAE (%) | -11.360% | -8.814% | -304.120% | N/A | 60.703% |
| Return on Capital Employed (%) | -10.070% | -8.673% | -101.699% | -182.027% | -28.538% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 89.585% | 97.417% | 84.402% | N/A | N/A |
| EBITDA Margin (%) | -99.794% | -303.491% | -3506.674% | N/A | N/A |
| Pre-tax Profit Margin (%) | -100.591% | -303.406% | -3530.124% | N/A | N/A |
| Net Profit Margin (%) | -101.486% | -307.921% | -3525.296% | N/A | N/A |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 9.356 X | 8.717 X | 31.960 X | 4.747 X | 7.241 X |
| Quick Ratio (X) | 9.177 X | 8.600 X | 31.814 X | 4.662 X | 7.195 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 23.078% | 15.083% | 7.347% | 306.588% | 141.902% |
| Total Debt / Total Assets (%) | 10.783% | 3.102% | 0.984% | 4.622% | 4.358% |
| Net Debt / Total Assets (%) | -11.134% | -12.260% | -37.665% | -33.007% | -61.330% |
| Total Debt / Shareholders' Funds (%) | 14.021% | 3.651% | 1.060% | N/A | N/A |
| Long Term Debt / Shareholders' Funds (%) | 11.836% | 1.489% | 0.739% | N/A | N/A |
| Net Debt / Shareholders' Funds (%) | -14.477% | -14.433% | -40.589% | N/A | N/A |
| Net Cash / (Debt) ($) | 432.320M | 482.101M | 1.482B | 174.917M | 403.907M |
| Net Cash / (Debt) per share ($) | 1.545 | 1.723 | 5.298 | -- | -- |
| Total Debt / Capital Employed (%) | 11.733% | 3.433% | 1.013% | 5.446% | 4.890% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 499.076 Day | 4298.669 Day | 246.577 Day | -- | -- |
| Receivables Turnover (Day) | 16.587 Day | N/A | N/A | N/A | N/A |
| Payables Turnover (Day) | 22.884 Day | 32.277 Day | 10.265 Day | N/A | N/A |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -336,745,000 |
| %Change | -- |
| EPS / (LPS) | RMB -1.290 |
| NBV Per Share (¥) | RMB 9.426 |